VERAXA Biotech completes merger, begins NASDAQ trading Jun 10, 2026 04:15PM
VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on June 11, 2026 Jun 10, 2026 04:15PM